SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OmniCorder Technologies, Inc. (OMCT)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RikRichter who started this subject1/8/2004 11:49:38 AM
From: RikRichter   of 63
 
Exhibits from this morning conference call to the financial community. OmniCorder target market is $23 billion broken down by screening/diagnostics ($12 billion), surgical ($7 billion) and therapy ($4 billion). The BioScan IR product is the lowest cost and least invasive product on the market.

Here is the summary of the CC exhibits:

omnicorder.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News